Literature DB >> 11883086

Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors.

Jonathan B Rohll1, Kyriacos A Mitrophanous, Enca Martin-Rendon, Fiona M Ellard, Pippa A Radcliffe, Nicholas D Mazarakis, Susan M Kingsman.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11883086     DOI： 10.1016/s0076-6879(02)46072-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  12 in total

1.  Oviduct-specific expression of two therapeutic proteins in transgenic hens.

Authors:  S G Lillico; A Sherman; M J McGrew; C D Robertson; J Smith; C Haslam; P Barnard; P A Radcliffe; K A Mitrophanous; E A Elliot; H M Sang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-26       Impact factor: 11.205

2.  Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.

Authors:  Mimoun Azzouz; Thanh Le; G Scott Ralph; Lucy Walmsley; Umrao R Monani; Debbie C P Lee; Fraser Wilkes; Kyriacos A Mitrophanous; Susan M Kingsman; Arthur H M Burghes; Nicholas D Mazarakis
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

3.  Functional conservation between rodents and chicken of regulatory sequences driving skeletal muscle gene expression in transgenic chickens.

Authors:  Michael J McGrew; Adrian Sherman; Simon G Lillico; Lorna Taylor; Helen Sang
Journal:  BMC Dev Biol       Date:  2010-02-25       Impact factor: 1.978

4.  Efficient production of germline transgenic chickens using lentiviral vectors.

Authors:  Michael J McGrew; Adrian Sherman; Fiona M Ellard; Simon G Lillico; Hazel J Gilhooley; Alan J Kingsman; Kyriacos A Mitrophanous; Helen Sang
Journal:  EMBO Rep       Date:  2004-06-11       Impact factor: 8.807

5.  Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.

Authors:  Jörg Zielonka; Ignacio G Bravo; Daniela Marino; Elea Conrad; Mario Perković; Marion Battenberg; Klaus Cichutek; Carsten Münk
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

6.  Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells.

Authors:  Michal Zalzman; Sanjeev Gupta; Ranjit K Giri; Irina Berkovich; Baljit S Sappal; Ohad Karnieli; Mark A Zern; Norman Fleischer; Shimon Efrat
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

7.  LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives.

Authors:  Faisal A Al-Allaf; Charles Coutelle; Simon N Waddington; Anna L David; Richard Harbottle; Michael Themis
Journal:  Int Arch Med       Date:  2010-12-13

8.  Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors.

Authors:  Daniel C Farley; Laura McCloskey; Barbara A Thorne; Semih U Tareen; Christopher J Nicolai; David J Campbell; Richard Bannister; Hannah J Stewart; Laura Je Pearson; Bentley J Moyer; Scott H Robbins; Leah Zielinski; Tae Kim; Pippa A Radcliffe; Kyriacos A Mitrophanous; Wayne R Gombotz; James E Miskin; Brenna Kelley-Clarke
Journal:  Mol Ther Methods Clin Dev       Date:  2015-05-13       Impact factor: 6.698

9.  Enhancing titres of therapeutic viral vectors using the transgene repression in vector production (TRiP) system.

Authors:  H E Maunder; J Wright; B R Kolli; C R Vieira; T T Mkandawire; S Tatoris; V Kennedy; S Iqball; G Devarajan; S Ellis; Y Lad; N G Clarkson; K A Mitrophanous; D C Farley
Journal:  Nat Commun       Date:  2017-03-27       Impact factor: 14.919

Review 10.  Production of lentiviral vectors.

Authors:  Otto-Wilhelm Merten; Matthias Hebben; Chiara Bovolenta
Journal:  Mol Ther Methods Clin Dev       Date:  2016-04-13       Impact factor: 6.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.